424 related articles for article (PubMed ID: 27413755)
1. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.
Gluhovschi C; Gluhovschi G; Petrica L; Timar R; Velciov S; Ionita I; Kaycsa A; Timar B
J Diabetes Res; 2016; 2016():4626125. PubMed ID: 27413755
[TBL] [Abstract][Full Text] [Related]
2. Diabetic nephropathy: traditional to proteomic markers.
Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
[TBL] [Abstract][Full Text] [Related]
3. Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.
Lee SY; Choi ME
Pediatr Nephrol; 2015 Jul; 30(7):1063-75. PubMed ID: 25060761
[TBL] [Abstract][Full Text] [Related]
4. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
[TBL] [Abstract][Full Text] [Related]
5. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
6. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
7. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
8. Insights into predicting diabetic nephropathy using urinary biomarkers.
Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
[TBL] [Abstract][Full Text] [Related]
9. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
[TBL] [Abstract][Full Text] [Related]
10. Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy.
Kishore L; Kaur N; Singh R
Curr Diabetes Rev; 2017; 13(6):598-605. PubMed ID: 27924722
[TBL] [Abstract][Full Text] [Related]
11. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
12. Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy.
Fukuda A; Minakawa A; Kikuchi M; Sato Y; Nagatomo M; Nakamura S; Mizoguchi T; Fukunaga N; Shibata H; Naik AS; Wiggins RC; Fujimoto S
Sci Rep; 2020 Oct; 10(1):18209. PubMed ID: 33097787
[TBL] [Abstract][Full Text] [Related]
13. The role of novel biomarkers in predicting diabetic nephropathy: a review.
Uwaezuoke SN
Int J Nephrol Renovasc Dis; 2017; 10():221-231. PubMed ID: 28860837
[TBL] [Abstract][Full Text] [Related]
14. Assessment of urinary osteopontin in association with podocyte for early predication of nephropathy in diabetic patients.
Al-Malki AL
Dis Markers; 2014; 2014():493736. PubMed ID: 24876663
[TBL] [Abstract][Full Text] [Related]
15. Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes.
Shoji M; Kobayashi K; Takemoto M; Sato Y; Yokote K
Biomarkers; 2016; 21(2):164-7. PubMed ID: 26635084
[TBL] [Abstract][Full Text] [Related]
16. Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system.
Vitova L; Tuma Z; Moravec J; Kvapil M; Matejovic M; Mares J
BMC Nephrol; 2017 Mar; 18(1):112. PubMed ID: 28359252
[TBL] [Abstract][Full Text] [Related]
17. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy.
Rossi L; Nicoletti MC; Carmosino M; Mastrofrancesco L; Di Franco A; Indrio F; Lella R; Laviola L; Giorgino F; Svelto M; Gesualdo L; Procino G
J Diabetes Res; 2017; 2017():4360357. PubMed ID: 28246612
[TBL] [Abstract][Full Text] [Related]
18. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
19. Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy.
Chen J; Zhang WW; Chen KH; Lin LR; Dai HZ; Li KL; Zhang JG; Zheng LQ; Fu BQ; He YN
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F273-F281. PubMed ID: 28356293
[TBL] [Abstract][Full Text] [Related]
20. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
